Retatrutide (10mg)
Triple-agonist metabolic research peptide
100 in stock
These products are intended for laboratory research purposes only, and are not for human or animal consumption. The products are not intended to diagnose, treat, cure, or prevent any disease. The products should not be used as a food, drug, cosmetic, or other household use.
Description
Properties
| Format | Lyophilized Powder |
| Terms | Laboratory research use only (RUO). Not for human, animal, diagnostic, or household use. |
2D Structure
2D Structure image coming soon.
About This Compound
Retatrutide is a novel triple-agonist peptide targeting GIP, GLP-1, and glucagon receptors. It is under investigation for its effects on metabolic pathways and body composition in preclinical research models. Highlights: Triple receptor agonist (GIP/GLP-1/Glucagon) | 99%+ purity verified via HPLC | Lyophilized powder form | Third-party tested. Specs: Format: Lyophilized Powder | Storage: -20°C | Purity: 99%+